IP Library Granted Patent US 6,921,638
Granted Patent B2
US 6,921,638 · App. 10/025,185 · Granted Jul 26, 2005

Hydrogel-based microarray signal amplification methods and devices therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,921,638
App. No.
10/025,185
Granted
Jul 26, 2005
Kind
B2
Abstract

Methods and devices for detecting nucleic acid and protein targets on hydrogel microarrays are disclosed. Fluorophores are incorporated into the targets and detected. A linear correlation between target concentration and signal amplitude is maintained through the elimination of active enzyme amplification.

Claims (46)

1. A method of detecting a target nucleic acid or protein, comprising:

(a) providing a target comprising a target nucleic acid or protein and a first member of a binding pair;

(b) hybridizing the target nucleic acid or protein to a probe attached to a hydrogel matrix through a 2+2 photocycloaddition;

(c) contacting the first member of the binding pair with a second member of the binding pair, said second member comprising a fluorophore; and

(d) detecting the fluorophore additions, thereby detecting said target nucleic acid or protein.

2. The method of claim 1 , wherein the first member comprises a first member selected from the group consisting of biotin, digoxygenin, and bromouridine.

3. The method of claim 2 , wherein the first member comprises biotin.

4. The method of claim 1 , wherein the second member is selected from the group consisting of avidin, streptavidin, biotin antibody, digoxygenin antibody, and bromouridine antibody.

5. The method of claim 4 , wherein the second member comprises streptavidin.

6. The method of claim 1 , wherein the nucleic acid is synthesized by producing a cDNA from a mRNA.

7. The method of claim 1 , wherein the nucleic acid is synthesized by producing a cDNA or a cRNA from a DNA.

8. The method of claim 1 , wherein the target is synthesized by incorporating the first member of a binding pair into the nucleic acid by polymerization.

9. The method of claim 1 , wherein the protein is from a cell lysate.

10. The method of claim 1 , wherein the hydrogel matrix comprises polyacrylamide.

11. The method of claim 1 , wherein the hydrogel matrix comprises polyurethane.

12. The method of claim 1 , wherein the probe comprises a reactive site capable of undergoing a 2+2 photocycloaddition.

13. The method of claim 1 , wherein the hydrogel matrix comprises a reactive site capable of undergoing a 2+2 photocycloaddition.

14. The method of claim 5 , wherein the streptavidin is attached to one or more fluorophores.

15. The method of claim 14 , wherein the streptavidin is attached to between three and four fluorophores.

16. The method of claim 1 , wherein said fluorophore is selected from the group consisting of cyanine dyes and ALEXA FLUOR dyes.

17. The method of claim 16 , wherein the cyanine dye is Cy-3, Cy-5, or Cy-5.5.

18. The method of claim 16 , wherein the ALEXA FLUOR dye is ALEXA-532, ALEXA-647, or ALEXA-633.

19. The method of claim 1 , wherein said fluorophore is ALEXA-647.

20. The method of claim 1 , further comprising contacting at least one of the second members of the binding pair with an antibody comprising a first member.

21. The method of claim 20 , wherein the antibody is a biotinylated anti-streptavidin antibody.

22. The method of claim 20 , wherein the first member comprises biotin and the second member comprises streptavidin attached to more than one fluorophore.

23. A method of detecting a single nucleotide polymorphism, comprising:

(a) hybridizing a target nucleic acid to a probe attached to a hydrogel matrix through a 2+2 photocycloaddition, said probe designed to terminate at the site of the single nucleotide polymorphism;

(b) extending the probe by one nucleotide, wherein the nucleotide comprises a first member of a binding pair;

(c) contacting the first member of the binding pair with a second member of the binding pair comprising a fluorophore; and

(d) detecting the fluorophore additions, thereby detecting the single nucleotide polymorphism.

24. The method of claim 23 , wherein the nucleotide is a dideoxynucleotide or an acyclonucleotide.

25. The method of claim 23 , wherein the nucleotide comprises the first member of the binding pair before said nucleotide is incorporated into the probe.

26. The method of claim 23 , wherein the first member of the binding pair is attached to the nucleotide after incorporation of the nucleotide into the probe.

27. The method of claim 23 , wherein the first member of the binding pair comprises biotin.

28. The method of claim 26 , wherein the second member of the binding pair comprises streptavidin.

29. The method of claim 23 , wherein the hydrogel matrix comprises polyacrylamide or polyurethane.

30. The method of claim 1 , wherein the probe comprises a reactive site capable of undergoing a 2+2 photocycloaddition.

31. The method of claim 28 , wherein the streptavidin is attached to more than one fluorophore.

32. The method of claim 23 , wherein said fluorophore is selected from the group consisting of cyanine dyes and ALEXA FLUOR dyes.

33. The method of claim 32 , wherein the cyanine dye is Cy-3, Cy-5, or Cy-5.5.

34. The method of claim 32 , wherein the ALEXA FLUOR dye is ALEXA-532, ALEXA-647, or ALEXA-633.

35. The method of claim 23 , wherein said fluorophore is ALEXA-647.

36. The method of claim 23 , further comprising contacting at least one of the second members of the binding pair with an antibody comprising a first member.

37. The method of claim 36 , wherein the antibody is a biotinylated anti-streptavidin antibody.

38. The method of claim 36 , wherein the first member comprises biotin and the second member comprises streptavidin attached to more than one fluorophore.

Assignments (1)
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →